Nestlé Launches First Product With HMOs In China

The product, which has been launched under the Wyeth illuma brand, follows on from the recent approval for the use of such bioactive ingredients by China’s National Health Commission.

HMOs are the third most abundant solid component in human breast milk, after lactose and lipids, Nestlé said, with the new product containing two of the three major types of HMOs, as well as healthy lipids and proteins that ‘play a role in gut and immune health and cognitive development’.

The new product will be manufactured at Nestlé’s factory in Suzhou, mainland China.

The first launch of HMO products in China brings the benefits of HMOs and 35 other vital ingredients in the illuma growing up milk to young children – the company reported, adding that the introduction of the illuma growing-up milk extends Nestlé’s expertise in HMO science throughout its formula brand lineup. With the recent launch of the Sinergity brand, Nestlé introduced a proprietary blend featuring a particular probiotic combined with six age-adapted human milk oligosaccharides (HMOs) to promote infant development and unlock specific health benefits.

ESM